STOCKHOLM, SWEDEN (UroToday.com) - Presented by Nick Freemantle,1 Kristin Khalaf,2 Daisy Ng-Mak,2,* Clara Loveman,3 Sanja Stanisic,4 Dmitry Gultyaev,5 Johanna Lister,5 and Marcus Drake6 at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
1Department of Primary Care and Population Health, UCL Medical School, London, United Kingdom; 2Allergan Inc., Irvine, CA, USA; 3Allergan Ltd, Marlow, United Kingdom; 4LA-SER ANALYTICA, Milan, Italy; 5LA-SER ANALYTICA, Lörrach, Germany; 6Department of Urology, Southmead Hospital, Bristol, United Kingdom *Currently Sunovion Pharmaceuticals Inc., Marlborough, MA, USA